Home
/
Treatment
/
2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol

2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol

	2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
Trade Name	Epidiolex
Orphan Indication	Dravet Syndrome
USA Market Approval	USA
USA Designation Date	2013-11-14 00:00:00
Sponsor	GW Pharma Ltd.;Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ;

Related Access Program

M. Scott Perry – Dravet Syndrome M. Scott Perry – Dravet Syndrome University of Colorado, Denver – Dravet Syndrome Children’s Hospital Medical Center, Cincinnati – Dravet Syndrome